MODULATEURS SÉLECTIFS DE L'ACTIVITÉ DU RÉCEPTEUR GPR55: DÉRIVÉS DE CHROME-OPIRAZOL

• 收藏
• 分享

专利权人:

Consejo Superior de Investigaciones Científicas (CSIC);The Governing Council of the University of Toronto

发明人:

JAGEROVIC, Nadine,MORALES LAZARO, Paula,ROSS, Ruth,WHYTE, Lauren

申请号：

EP16789355

公开号：

EP3305794A4

申请日:

2016.04.27

申请国别(地区):

EP

年份:

2018

代理人:

摘要：

The present invention relates to a family of chromenopyrazole derivatives of formula (I): which have the ability to modulate the receptor of the cannabinoid family GPR55, whereby the invention also relates to the use of these compounds for the manufacture of a medicament for the treatment of diseases in which the GPR55 receptor has a physiological role such as diabetes, Parkinson's disease, multiple sclerosis, neuropathic pain, osteoporosis and cancers such as cholangiocarcinoma, breast cancer, ovarian and prostate cancer, glioblastoma, and cutaneous carcinoma.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/